Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>Products>Product News
  Product News
Bruker Announces Powerful New Mass Spectrometry Systems and Solutions
Tuesday, June 11, 2013
Company announces mass spectrometry-based product introductions for life-science research, clinical research, pharma and applied markets.

Bruker Unveils Mass Spectrometry-Based Products at ASMS
Monday, June 10, 2013
Bruker announces powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets.

Metabolon Expands Biochemical Profiling Capabilities
Wednesday, April 24, 2013
New TrueVision™ offering combines Company’s powerful biochemical profiling discovery platform with complex lipid profiling.

Extended Mass Spec Imaging Services Now Available
Tuesday, April 16, 2013
Mass Spec Imaging Center offers MSI service.

EZ Access To Evaporator Information
Wednesday, January 09, 2013
Genevac has created a web microsite dedicated to providing visitors with easy access to comprehensive background information relating to its flagship EZ-2 Series of compact, benchtop personal evaporators.

Agilent and PREMIER Biosoft’s Platforms Work Together to Advance Lipidomics Research
Monday, October 29, 2012
Complementary tools eliminate bottlenecks in data processing and analysis.

ISLAB Benefits from LGC Standards’ Ready-to-Use LoGiCal® Solutions
Tuesday, October 16, 2012
Reference materials are both reasonably priced and very good quality.

BASF subsidiary Metanomics Health launches MetaMap®Tox
Monday, August 13, 2012
MetaMap®Tox is a service evaluating specific metabolomic patterns in vivo, enabling customers to better and faster identify potential safety risks of test compounds in in vivo studies of rats. Developed in-house by BASF’s Experimental Toxicology and Ecology unit and marketed through Metanomics Health, MetaMap®Tox addresses key unmet needs for in vivo toxicology testing: predictability, understanding of a toxicology mechanism and the ability for translation to clinical use.

KU to Partner with Bayer HealthCare on Portable Glucose Monitor
Thursday, July 26, 2012
KU’s new advanced design studies 560 class will work to develop applications for Bayer’s Contour USB meter.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 350
Scientific News
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
‘Big Data’ Drills Down Into Metabolic Details
Rice University bioengineers introduce efficient way to analyze, compare tissue-specific pathways.
New Approach to Curbing Cancer Cell Growth
Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.
New Drug Delivery Method for Pancreatic Cancer
UCLA researchers use nanoparticles to send chemotherapy drug directly to the tumor site, reducing damage to healthy tissues.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!